WithHealth Appoints Seasoned Marketing Executive Cindy Judd as its Chief Marketing Officer
Brings Expertise in Creating and Directing Global Marketing Initiatives SAN DIEGO, CA / ACCESSWIRE / March 22, 2021 / WithHealth,...
Staff
Enzolytics Announces the Filing of Updated NIH Grant Applications Incorporating Newly Identified Conserved Epitopes on Both the HIV-1 and SARS-CoV-2 Viruses; Other Corporate Updates
COLLEGE STATION, TX / ACCESSWIRE / March 22, 2021 / Enzolytics, Inc. (OTC PINK:ENZC or the "Company") today announced it has...
Novamind to Present at Benzinga Biotech Conference
Panel discussion on psychedelic treatments and therapies to feature Novamind's Chief Medical Officer TORONTO, ON / ACCESSWIRE / March 22,...
Sonnet BioTherapeutics Appoints Richard Kenney as Chief Medical Officer and Manuel Dafonseca as Head of Clinical Operations
PRINCETON, NJ / ACCESSWIRE / March 22, 2021 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical...
The PHAZER Universe is Coming to Liquid Avatar with Integrated Multi-Media, Avatars and AR-Enhanced, Cinematic Collector NFTs
Apex Comics Group brings its iconic characters to the world of digital collectibles with virtual unveiling at WonderCon March 26...
Castellum, Inc. Announces Brigadier General Craig Nixon, U.S. Army Retired to Join Advisory Board
Brigadier General Craig Nixon, U.S. Army Retired, Joins Castellum, Inc. Castellum, Inc. (OTC: ONOV) announces Brigadier General Craig Nixon has...
Chiesi continues cultural transformation with new visual identity that mirrors patients’ language and experiences
New visual identity is the first public manifestation of Chiesi Group’s continued transformation as a Certified B Corporation™ businessPatients’ experiences...
Fortress Biotech’s Partner Company, Journey Medical Corporation, In-licenses and Launches Accutane® for the Treatment of Severe Recalcitrant Nodular Acne
Accutane is Journey Medical’s sixth marketed dermatology product IMPORTANT SAFETY INFORMATION CAUSES BIRTH DEFECTS - DO NOT GET PREGNANT NEW...
INmune Bio, Inc. Announces Professor Mark Lowdell, PhD, CSO to Deliver Presentations at Two Upcoming Medical Meetings
Innate Killer Digital Summit 2021, which is being held March 23-25 Festival of Biologics USA: World Immunotherapy Congress 2021, which...
Repeat: Core One Labs Files Application to List its Common Shares on NASDAQ
VANCOUVER, British Columbia, March 22, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN:...
AIM ImmunoTech Announces Addition of Single-Agent Ampligen Arm to Cancer Center’s Ongoing Study in Cancer Patients with COVID-19
OCALA, Fla., March 22, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that the Institutional Review...
Jushi Holdings Inc. to Report Fourth Quarter and Full Year 2020 Financial Results on April 29, 2021
BOCA RATON, Fla., March 22, 2021 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCMKTS: JUSHF),...
Else Nutrition Holdings Inc. to Webcast Live at Life Sciences Investor Forum March 25th
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.comVANCOUVER, British...
VolitionRx Limited to Webcast Live at Life Sciences Investor Forum March 25th
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.comAUSTIN, Texas,...
MagicMed Industries to Webcast Live at Life Sciences Investor Forum on March 25th
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.comCALGARY, Alberta,...
Starton Therapeutics Completes Pre-IND Meeting with FDA: Clearing Path to Phase 1 Clinical Study for STAR-LLD Continuous Infusion
PARAMUS, N.J., March 22, 2021 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical stage biotechnology company...
Relief and Acer Therapeutics Sign Collaboration and License Agreement for Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Urine Disease
Relief to potentially pay Acer up to $36 million and royalties in exchange for net profit share and territory rights...
VistaGen’s Poster Presentation at the Anxiety and Depression Association of America’s 2021 Annual Conference Differentiates PH94B’s Mechanism of Action from Highly-Addictive Benzodiazepines
SOUTH SAN FRANCISCO, Calif., March 22, 2021 (GLOBE NEWSWIRE) -- VistaGen Therapeutics, Inc. (NASDAQ: VTGN), a biopharmaceutical company committed to...
Reviva Pharmaceuticals Holdings, Inc. Reports 2020 Financial Results and Provides Corporate Update
-Closed Merger with Tenzing Acquisition Corp and publicly listed on NASDAQ Capital Market- -Plans to initiate a pivotal Phase 3 trial...
Dyadic and Medytox To Develop Vaccines Against COVID-19 Variants
Expanding existing COVID-19 vaccine research collaboration which began in July 2020.Medytox and Dyadic to co-develop C1 enabled COVID-19 vaccines and/or...